https://www.selleckchem.com/pr....oducts/qnz-evp4593.h
The efficacy of interleukin-6 receptor blockade in hospitalized patients with coronavirus disease 2019 (Covid-19) who are not receiving mechanical ventilation is unclear. We performed a randomized, double-blind, placebo-controlled trial involving patients with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, hyperinflammatory states, and at least two of the following signs fever (body temperature 38°C), pulmonary infiltrates, or the need for supplemental oxygen in order to maintain an oxygen satu
Me gusta
Comentario
Compartir
